ReviewHepatology international2026
Another ciliopathy? Uncovering the ciliary basis of biliary atresia.
Review in Hepatology international, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundBiliary atresia (BA) is a rare but severe neonatal cholangiopathy characterized by progressive fibro-inflammatory obstruction of the bile ducts, ultimately leading to liver failure and the need for liver transplants. Despite intensive researches, the etiology of BA remains poorly understood. Recent discoveries implicate primary cilia-solitary, microtubule-based organelles that regulate developmental signaling pathways-as central to the pathogenesis of both syndromic and non-syndromic BA.
methodsWe systematically reviewed genetic, histological, organoid-based, and animal model studies that investigate the role of primary cilia in BA. Evidence was synthesized across genome-wide association studies, sequencing analyses, tissue-level ciliary assessments, and functional perturbation experiments in model organisms to integrate current understanding of ciliary defects and their mechanistic contribution to BA.
resultsGenetic analyses identified both common and rare variants in cilia-related genes-polycystin 1 like 1 (PKD1L1), kinesin family member 3B (KIF3B), tetratricopeptide repeat domain 17 (TTC17), and ciliogenesis and planar polarity effector (CPLANE) complex members-particularly in BA patients with laterality defects. Histological evaluation of BA liver tissues consistently demonstrated shortened, misoriented, or absent cholangiocyte cilia, while patient-derived organoids reproduced these structural abnormalities alongside disrupted epithelial polarity. Functional studies in zebrafish and mouse models showed that loss of ciliary genes impaired bile duct morphogenesis, delayed biliary drainage, and induced progressive cholangiopathy, closely mirroring human BA. Perturbation of cilia-dependent signaling pathways, including Hedgehog (Hh), further exacerbated disease phenotypes, underscoring the causal role of ciliary dysfunction.
conclusionsTaken together, these findings support the emerging view of BA as a cilia-related developmental disorder. This review offers new insights into disease mechanisms and provides a basis for advancing early diagnosis, risk stratification, and targeted therapeutic strategies of BA.
Indexed as
Identifiers
41405813What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.